Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) Change in Receivables (2017 - 2020)

Historic Change in Receivables for Cogent Biosciences (COGT) over the last 4 years, with Q1 2020 value amounting to -$2.0 million.

  • Cogent Biosciences' Change in Receivables fell 63763.44% to -$2.0 million in Q1 2020 from the same period last year, while for Dec 2020 it was -$2.0 million, marking a year-over-year decrease of 70240.96%. This contributed to the annual value of -$2.0 million for FY2020, which is 70240.96% down from last year.
  • Cogent Biosciences' Change in Receivables amounted to -$2.0 million in Q1 2020, which was down 63763.44% from $1.1 million recorded in Q4 2019.
  • Cogent Biosciences' 5-year Change in Receivables high stood at $1.1 million for Q4 2019, and its period low was -$2.0 million during Q1 2020.
  • Its 4-year average for Change in Receivables is -$71384.6, with a median of $217000.0 in 2018.
  • Its Change in Receivables has fluctuated over the past 5 years, first surged by 198048.78% in 2018, then plummeted by 63763.44% in 2020.
  • Cogent Biosciences' Change in Receivables (Quarter) stood at -$681000.0 in 2017, then surged by 136.56% to $249000.0 in 2018, then surged by 349.8% to $1.1 million in 2019, then tumbled by 278.57% to -$2.0 million in 2020.
  • Its last three reported values are -$2.0 million in Q1 2020, $1.1 million for Q4 2019, and -$612000.0 during Q3 2019.